AMORCHEM
AmorChem l.p., our fourth focused fund, was launched in 2011 to increase the commercial potential of the quality academic research carried out in Quebec. AmorChem is focused on investing in promising life science projects originating from Québec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept in a semi-virtual mode. AmorChem will generate returns through a two-pronged exit strategy:
AMORCHEM
Industry:
Venture Capital
Founded:
2011-01-01
Status:
Active
Contact:
514-283-3602
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Tag Manager WordPress Mobile Non Scaleable Content Sitelinks Search Box Yoast WordPress SEO Plugin Person Schema Yoast Plugins Yoast SEO Premium
Similar Organizations
Aisles Capital
Future-focused AI-driven investments for optimal returns and sustainable growth.
Bridge Latam
Bridge Latam is a Seed stage fund based in Mexico investing in Latam-based companies.
Dash Fund
Backing the next wave of category-defining founders and companies.
Headline
Headline is a global venture capital firm investing in winning teams across stages and geographies.
Oregon Venture Fund
Oregon Venture Fund is a venture capital fund that provides funding and support to build the next generation of growth companies.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Soma Capital
Soma Capital is venture capital fund that focuses on investing in software to automate the world across all sectors and geographies.
Current Employees Featured
Founder
Investors List
Venture Capital Catalyst Initiative (VCCI)
Venture Capital Catalyst Initiative (VCCI) investment in Grant - Amorchem
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-10-17 | Inversago Pharma | Amorchem investment in Series C - Inversago Pharma | 95 M CAD |
| 2021-05-21 | Giiant Pharma | Amorchem investment in Seed Round - Giiant Pharma | 15 M CAD |
| 2020-09-08 | Inversago Pharma | Amorchem investment in Series B - Inversago Pharma | 35 M USD |
| 2020-07-16 | Liminal BioSciences | Amorchem investment in Post-IPO Equity - Liminal BioSciences | 2.4 M CAD |
| 2018-07-25 | Inversago Pharma | Amorchem investment in Series A - Inversago Pharma | 7 M USD |
| 2018-03-26 | Semathera | Amorchem investment in Venture Round - Semathera | 2.6 M USD |
| 2017-09-11 | SpecificiT Pharma | Amorchem investment in Seed Round - SpecificiT Pharma | N/A |
More informations about "Amorchem"
Creating - Amorchem
At AmorChem, we are leading experts invested in the creation of next generation biotechs by harnessing academic entrepreneurship to generate sustainable health and wealth We utilize our deep understanding of fundamental science …See details»
NuChem Sciences Inc. - Amorchem
NuChem Sciences Inc. (https://nuchemsciences.com) is an early-stage drug discovery contract research organization that was started and funded by AmorChem in 2011. Since then, the …See details»
Amorchem - Crunchbase Investor Profile & Investments
AmorChem l.p., our fourth focused fund, was launched in 2011 to increase the commercial potential of the quality academic research carried out in Quebec. AmorChem is focused on …See details»
AmorChem - LinkedIn
AmorChem is an early stage life science venture capital fund, which is a major supporter of Quebec’s academic innovation. The fund mainly focuses on pre-seed and seed investments …See details»
Investor Spotlight: AmorChem @ JLABS — OBIO - Ontario …
On September 27th, Elizabeth Douville, Inès Holzbaur, and Maxime Ranger from AmorChem will present an overview of the firm, its investment strategy, its primary areas of interest, and a few …See details»
Amorchem - Investments, Portfolio & Company Exits - Crunchbase
Amorchem 's most notable exits include Inversago Pharma and Liminal BioSciences. Which industries has this organization had the most exits in? Show . Inversago Pharma Inversago …See details»
AmorChem Investor Profile: Portfolio & Exits - PitchBook
AmorChem General Information Company Description. Founded in 2011, AmorChem is a venture capital firm based in Quebec, Canada. The firm seeks to invest in early-stage life science & …See details»
AmorChem I: Fund Performance - PitchBook
AmorChem I is a venture capital fund managed by GeneChem and AmorChem. The fund is located in Westmount, Quebec and invests in Quebec. The fund targets to invest in the …See details»
Building - Amorchem
At AmorChem we believe in the power of collaboration to help us transform biotech start ups into next gen companies. Since 2011 we have taken great care in building a community made up of passionate academics, students, …See details»
Amorchem - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 5, 2018: Grant - …See details»
AmorChem II: Fund Performance - PitchBook
AmorChem II is a 2018 vintage venture capital fund co-managed by GeneChem and AmorChem. The fund is located in Westmount, Quebec and will invest in Quebec. The fund targets …See details»
AmorChem / AmorChem / Jean Michel Laurin, Consultant
AmorChem / AmorChem is not a coalition. Individual, organization or corporation with a Direct Interest Beneficiary Information The activities of AmorChem / AmorChem are not controlled or …See details»
Amorchem - Contacts, Employees, Board Members, Advisors
Amorchem has 4 current employee profiles, including Founder & Partner Elizabeth Douville. Contacts. Edit Contacts Section. Job Department. Protected Content. Founder and Managing …See details»
New Company to Advance Research into Made-in-Canada …
Jun 4, 2020 AmorChem is a leading early stage venture capital fund, investing ground-breaking academic innovation. ... Organization Profile. adMare BioInnovations. Contact Cision. 866-245 …See details»
AmorChem partners on project to treat endometriosis and ... - PE …
Nov 19, 2013 AmorChem, an early-stage life sciences fund managed by Canadian venture capital firm GeneChem, has partnered with the Université Laval and CHU de Québec on a …See details»
ATP Synthase - Amorchem
Developing bacterial ATP synthase inhibitors as novel broad-spectrum antibiotics Antibiotic resistance is a well-known medical and public health challenge. New antibiotics are required …See details»
Amorchem closes $44.2 million for biotech fund - BetaKit
Dec 8, 2017 AmorChem has raised a $44.2 million second fund to invest in seed-stage biotechnology companies. AmorChem II was backed by the Québec government, Fonds de …See details»
Portfolio - Amorchem
At AmorChem we believe in the power of collaboration to help us transform biotech start ups into next gen companies. Since 2011 we have taken great care in building a community made up …See details»
News - Amorchem
May 21, 2024 AmorChem’s RNA Zipcode delivery technology investment exits via New York-based Kodikaz Therapeutic Solutions, Inc. Read article August 10, 2023 Novo Nordisk to …See details»